DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tyzeka (Telbivudine) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

WARNINGS

Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination with antiretrovirals.

Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including TYZEKA (telbivudine). Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, resumption of anti-hepatitis B therapy may be warranted. (See WARNINGS .)

 

TYZEKA SUMMARY

TYZEKA
(telbivudine) Tablets
Rx only
Prescribing Information

TYZEKA is the trade name for telbivudine, a synthetic thymidine nucleoside analogue with activity against hepatitis B virus (HBV).

TYZEKA (telbivudine) is indicated for the treatment of chronic hepatitis B in adult patients with evidence of viral replication and   either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

This indication is based on virologic, serologic, biochemical and histologic responses after one year of treatment in nucleoside-treatment-naïve adult patients with HBeAg-positive and HBeAg-negative chronic hepatitis B with compensated liver disease (See Description of Clinical Studies).


See all Tyzeka indications & dosage >>

TYZEKA NEWS HIGHLIGHTS

Published Studies Related to Tyzeka (Telbivudine)

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial. [2008.02]

Telbivudine versus lamivudine in patients with chronic hepatitis B. [2007.12.20]

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial. [2007.12.04]

Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis with Telbivudine or Adefovir: A Randomized Trial. [2007.10.01]

Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications. [2006.03]

more >>

Clinical Trials Related to Tyzeka (Telbivudine)

Efficacy and Safety of Telbivudine in Treatment naïve Patients With HBeAg-Positive Chronic Hepatitis B (CHB) [Terminated]

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B [Active, not recruiting]

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B [Recruiting]

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies [Active, not recruiting]

Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy [Withdrawn]

more >>

Page last updated: 2008-03-26

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008